Active 0 6 0 6 O
/ 6 7 6 7 O
acute 7 12 7 12 B-chronic_disease
pancreatitis 13 25 13 25 I-chronic_disease
with 26 30 26 30 O
hyperlipidemia 31 45 31 45 B-chronic_disease

Allergy 0 7 46 53 O
to 8 10 54 56 O
egg 11 14 57 60 B-allergy_name
, 14 15 60 61 O
fish 16 20 62 66 B-allergy_name
, 20 21 66 67 O
or 22 24 68 70 O
soy 25 28 71 74 B-allergy_name
/ 28 29 74 75 O
legume 29 35 75 81 B-allergy_name
products 36 44 82 90 I-allergy_name

Diagnosis 0 9 91 100 O
of 10 12 101 103 O
a 13 14 104 105 O
hematological 15 28 106 119 B-cancer
malignancy 29 39 120 130 I-cancer
including 40 49 131 140 O
myelodysplasia 50 64 141 155 B-chronic_disease

GVHD 0 4 156 160 B-chronic_disease
prophylaxis 5 16 161 172 B-treatment
that 17 21 173 177 O
includes 22 30 178 186 O
rapamycin 31 40 187 196 B-treatment

History 0 7 197 204 O
of 8 10 205 207 O
parenteral 11 21 208 218 B-treatment
nutrition 22 31 219 228 I-treatment
use 32 35 229 232 I-treatment
with 36 40 233 237 I-treatment
SOLE 41 45 238 242 I-treatment
prior 46 51 243 248 I-treatment
to 52 54 249 251 I-treatment
HCT 55 58 252 255 I-treatment

Lipid 0 5 256 261 B-chronic_disease
nephrosis 6 15 262 271 I-chronic_disease

Other 0 5 272 277 O
contraindication 6 22 278 294 O
to 23 25 295 297 O
PN 26 28 298 300 B-treatment
or 29 31 301 303 O
intravenous 32 43 304 315 B-treatment
lipids 44 50 316 322 I-treatment

Pathological 0 12 323 335 O
hyperlipidemia 13 27 336 350 B-chronic_disease
( 28 29 351 352 O
2 29 30 352 353 O
consecutive 31 42 354 365 O
fasting 43 50 366 373 B-clinical_variable
triglyceride 51 63 374 386 I-clinical_variable
levels 64 70 387 393 I-clinical_variable
> 71 72 394 395 O
500 73 76 396 399 B-lower_bound
mg 77 79 400 402 I-lower_bound
/ 79 80 402 403 I-lower_bound
dL 80 82 403 405 I-lower_bound
) 82 83 405 406 O

Planned 0 7 407 414 O
myeloablative 8 21 415 428 O
allogeneic 22 32 429 439 O
bone 33 37 440 444 O
marrow 38 44 445 451 O
, 44 45 451 452 O
cord 46 50 453 457 O
, 50 51 457 458 O
or 52 54 459 461 O
peripheral 55 65 462 472 O
blood 66 71 473 478 O
stem 72 76 479 483 O
cell 77 81 484 488 O
( 82 83 489 490 O
from 83 87 490 494 O
any 88 91 495 498 O
donor 92 97 499 504 O
, 97 98 504 505 O
including 99 108 506 515 O
haploidentical 109 123 516 530 O
donor 124 129 531 536 O
) 129 130 536 537 O
HCT 131 134 538 541 B-treatment
conditioning 135 147 542 554 I-treatment
regimen 148 155 555 562 I-treatment
using 156 161 563 568 O
either 162 168 569 575 O
TBI 169 172 576 579 B-chronic_disease
( 173 174 580 581 O
planned 174 181 581 588 B-clinical_variable
cumulative 182 192 589 599 I-clinical_variable
dose 193 197 600 604 I-clinical_variable
> 198 199 605 606 O
1100 199 203 606 610 B-lower_bound
cGy 204 207 611 614 I-lower_bound
) 207 208 614 615 O
or 209 211 616 618 O
busulfan 212 220 619 627 B-treatment
in 221 223 628 630 O
addition 224 232 631 639 O
to 233 235 640 642 O
other 236 241 643 648 O
chemotherapeutic 242 258 649 665 B-treatment
agents 259 265 666 672 I-treatment

Planned 0 7 673 680 O
related 8 15 681 688 O
or 16 18 689 691 O
unrelated 19 28 692 701 O
bone 29 33 702 706 O
marrow 34 40 707 713 O
donor 41 46 714 719 O
matched 47 54 720 727 O
at 55 57 728 730 O
a 58 59 731 732 O
minimum 60 67 733 740 O
of 68 70 741 743 O
out 71 74 744 747 O
of 75 77 748 750 O
10 78 80 751 753 B-upper_bound
human 81 86 754 759 B-clinical_variable
leukocyte 87 96 760 769 I-clinical_variable
antigen 97 104 770 777 I-clinical_variable
( 105 106 778 779 I-clinical_variable
HLA 106 109 779 782 I-clinical_variable
) 109 110 782 783 I-clinical_variable
loci 111 115 784 788 O
( 116 117 789 790 O
HLA 117 120 790 793 B-clinical_variable
- 120 121 793 794 I-clinical_variable
A 121 122 794 795 I-clinical_variable
, 122 123 795 796 O
-B 124 126 797 799 O
, 126 127 799 800 O
-C 128 130 801 803 O
, 130 131 803 804 O
-DRB1 132 137 805 810 O
, 137 138 810 811 O
and 139 142 812 815 O
-DQ 143 146 816 819 O
) 146 147 819 820 O

Recent 0 6 821 827 O
stroke 7 13 828 834 B-chronic_disease
, 13 14 834 835 O
cardiac 15 22 836 843 B-chronic_disease
infarction 23 33 844 854 I-chronic_disease
or 34 36 855 857 O
embolism 37 45 858 866 B-chronic_disease

Unstable 0 8 867 875 O
diabetes 9 17 876 884 B-chronic_disease
mellitus 18 26 885 893 I-chronic_disease

active 0 6 894 900 O
/ 6 7 900 901 O
acute 7 12 901 906 B-chronic_disease
pancreatitis 13 25 907 919 I-chronic_disease
with 26 30 920 924 O
hyperlipidemia 31 45 925 939 B-chronic_disease

allergy 0 7 940 947 O
to 8 10 948 950 O
egg 11 14 951 954 B-allergy_name
, 14 15 954 955 O
fish 16 20 956 960 B-allergy_name
, 20 21 960 961 O
or 22 24 962 964 O
soy 25 28 965 968 B-allergy_name
/ 28 29 968 969 O
legume 29 35 969 975 B-allergy_name
products 36 44 976 984 I-allergy_name

co 0 2 985 987 O
- 2 3 987 988 O
enrollment 3 13 988 998 O
in 14 16 999 1001 O
other 17 22 1002 1007 O
interventional 23 37 1008 1022 B-treatment
clinical 38 46 1023 1031 I-treatment
studies 47 54 1032 1039 I-treatment

lipid 0 5 1040 1045 B-chronic_disease
nephrosis 6 15 1046 1055 I-chronic_disease

other 0 5 1056 1061 O
contraindication 6 22 1062 1078 O
to 23 25 1079 1081 O
PN 26 28 1082 1084 B-treatment
or 29 31 1085 1087 O
intravenous 32 43 1088 1099 B-treatment
lipids 44 50 1100 1106 I-treatment

pathological 0 12 1107 1119 O
hyperlipidemia 13 27 1120 1134 B-chronic_disease
( 28 29 1135 1136 O
2 29 30 1136 1137 O
consecutive 31 42 1138 1149 O
fasting 43 50 1150 1157 B-clinical_variable
triglyceride 51 63 1158 1170 I-clinical_variable
levels 64 70 1171 1177 I-clinical_variable
> 71 72 1178 1179 O
500 73 76 1180 1183 B-lower_bound
mg 77 79 1184 1186 I-lower_bound
/ 79 80 1186 1187 I-lower_bound
dL 80 82 1187 1189 I-lower_bound
) 82 83 1189 1190 O

planned 0 7 1191 1198 O
related 8 15 1199 1206 O
or 16 18 1207 1209 O
unrelated 19 28 1210 1219 O
cord 29 33 1220 1224 O
blood 34 39 1225 1230 O
donor 40 45 1231 1236 O
matched 46 53 1237 1244 O
at 54 56 1245 1247 O
a 57 58 1248 1249 O
minimum 59 66 1250 1257 O
of 67 69 1258 1260 O
4 70 71 1261 1262 B-lower_bound
out 72 75 1263 1266 O
of 76 78 1267 1269 O
6 79 80 1270 1271 B-upper_bound
HLA 81 84 1272 1275 B-clinical_variable
loci 85 89 1276 1280 I-clinical_variable
( 90 91 1281 1282 O
HLA 91 94 1282 1285 B-clinical_variable
- 94 95 1285 1286 I-clinical_variable
A 95 96 1286 1287 I-clinical_variable
, 96 97 1287 1288 O
-B 98 100 1289 1291 B-clinical_variable
, 100 101 1291 1292 O
and 102 105 1293 1296 O
-DRB1 106 111 1297 1302 O
) 111 112 1302 1303 O

recent 0 6 1304 1310 O
stroke 7 13 1311 1317 B-chronic_disease
, 13 14 1317 1318 O
cardiac 15 22 1319 1326 B-chronic_disease
infarction 23 33 1327 1337 I-chronic_disease
or 34 36 1338 1340 O
embolism 37 45 1341 1349 O

unstable 0 8 1350 1358 O
diabetes 9 17 1359 1367 B-chronic_disease
mellitus 18 26 1368 1376 I-chronic_disease

